DAX FDA Approval of Lynkuet Marks Strategic Milestone for Bayer
Bayer has secured U.S. Food and Drug Administration (FDA) approval to market Lynkuet, its non-hormonal treatment for menopausal symptoms. The clearance provides the German pharmaceutical and life sciences group with...